Earnings Data
Report Date
Nov 04, 2026TBA (Confirmed)
Period Ending
2026 (Q3)Consensus EPS Forecast
-14.75Last Year’s EPS
-30.73Same Quarter Last Year
Moderate Buy
Based on 19 Analysts Ratings
MX:RARE Q2 2026 Earnings Report
MX:RARE Upcoming Earnings
Ultragenyx Pharmaceutical's next earnings date is estimated for November 4, 2026, based on past reporting schedules.
MX:RARE Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
MX:RARE Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 04, 2026 | $811.00 | $811.00 | 0.00% |
May 05, 2026 | $811.00 | $811.00 | 0.00% |
Feb 12, 2026 | $811.00 | $811.00 | 0.00% |
Nov 04, 2025 | $811.00 | $811.00 | 0.00% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Ultragenyx Pharmaceutical (MX:RARE) report earnings?
Ultragenyx Pharmaceutical (MX:RARE) is schdueled to report earning on Nov 04, 2026, TBA (Confirmed).
What is Ultragenyx Pharmaceutical (MX:RARE) earnings time?
Ultragenyx Pharmaceutical (MX:RARE) earnings time is at Nov 04, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Ultragenyx Pharmaceutical stock?
The P/E ratio of Ultragenyx Pharmaceutical is N/A.
What is MX:RARE EPS forecast?
MX:RARE EPS forecast for the fiscal quarter 2026 (Q3) is -14.75.